Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_provenance.
- NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_assertion description "[This study was conducted to (a) determine the effect of Cetuximab on invasion and NSCLC-metastasis; (b) investigate urokinase-type plasminogen activator receptor (u-PAR), a major molecule promoting invasion and metastasis, as a target molecule; (c) delineate molecular mediators of Cetuximab-induced metastasis inhibition; and (d) identify biomarkers of drug sensitivity in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_provenance.
- NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_assertion evidence source_evidence_literature NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_provenance.
- NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_assertion SIO_000772 19276367 NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_provenance.
- NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_assertion wasDerivedFrom befree-20140225 NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_provenance.
- NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_assertion wasGeneratedBy ECO_0000203 NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP514498.RAJV4e-nm_VFYTNX-4cXQ3Xqby2SWNneHPuMSUxnZzeRc130_provenance.